Operating activities | |
Net income | -1.68M |
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities: | |
Depreciation and amortization | 936K |
Share-based compensation | 264K |
Amortization of deferred gain | |
Amortization of debt issuance costs | 136K |
Reversal of deferred tax asset valuation allowance | |
Excess tax benefits related to share-based compensation | |
Other | |
Changes in assets and liabilities: | |
Accounts receivable | 2M |
Inventories | 385K |
Other current assets | |
Other assets | -37K |
Accounts payable and accrued expenses | |
Income taxes payable | 859K |
Net cash flows provided by operating activities | |
Investing activities | |
Purchase of property and equipment | -244K |
Decrease (increase) in restricted cash | |
Proceeds from sale of property and equipment | 0 |
Consolidation of ARCA Advanced Processing (AAP) | |
Net cash flows used in investing activities | |
Financing activities | |
Checks issued in excess of cash in bank | |
Net borrowings (payments) under line of credit | -2.86M |
Payments on debt obligations | -821K |
Proceeds from issuance of debt obligations | 100K |
Proceeds from issuance of Common Stock, net of offering costs | 0 |
Payment of debt issuance costs | -125K |
Excess tax benefits related to share-based compensation | |
Net cash flows provided by (used in) financing activities | |
Effect of changes in exchange rate on cash and cash equivalents | |
Increase in cash and cash equivalents | -260K |
Cash and cash equivalents at beginning of period | 1.97M |
Cash and cash equivalents at end of period | 1.71M |
Supplemental disclosures of cash flow information | |
Cash payments for interest | |
Cash payments for income taxes | 860K |
Non-cash investing and financing activities | |
Loan receivable exchanged for equity in AAP | |
Equipment acquired under capital leases | |
Consolidation of variable interest entity: | |
Fair value of assets acquired | |
Assumed liabilities |